Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Functional Neuroimaging for Addiction Medicine: From Mechanisms to Practical Considerations Publisher Pubmed



Ekhtiari H1, 2, 3 ; Faghiri A1, 4 ; Oghabian MA1, 5 ; Paulus MP6, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Neurocognitive Laboratory, Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Translational Neuroscience Program, Institute for Cognitive Sciences Studies (ICSS), Tehran, Iran
  4. 4. Department of Electrical Engineering, Sharif University of Technology, Tehran, Iran
  5. 5. Advanced Diagnostic and Interventional Radiology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Laureate Institute for Brain Research, Tulsa, OK, United States
  7. 7. Department of Psychiatry, University of California at San Diego, San Diego, CA, United States

Source: Progress in Brain Research Published:2016


Abstract

During last 20 years, neuroimaging with functional magnetic resonance imaging (fMRI) in people with drug addictions has introduced a wide range of quantitative biomarkers from brain's regional or network level activities during different cognitive functions. These quantitative biomarkers could be potentially used for assessment, planning, prediction, and monitoring for addiction medicine during screening, acute intoxication, admission to a program, completion of an acute program, admission to a long-term program, and postgraduation follow-up. In this chapter, we have briefly reviewed main neurocognitive targets for fMRI studies associated with addictive behaviors, main study types using fMRI among drug dependents, and potential applications for fMRI in addiction medicine. Main challenges and limitations for extending fMRI studies and evidences aiming at clinical applications in addiction medicine are also discussed. There is still a significant gap between available evidences from group-based fMRI studies and personalized decisions during daily practices in addiction medicine. It will be important to fill this gap with large-scale clinical trials and longitudinal studies using fMRI measures with a well-defined strategic plan for the future. © 2016 Elsevier B.V.